Literature DB >> 12325082

Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.

Anne Fogli1, Kondi Wong, Eleonore Eymard-Pierre, Jack Wenger, John-Paul Bouffard, Ehud Goldin, Deborah N Black, Odile Boespflug-Tanguy, Raphael Schiffmann.   

Abstract

Cree leukoencephalopathy is a rapidly fatal infantile autosomal recessive leukodystrophy of unknown cause observed in the native North American Cree and Chippewayan indigenous population. We found in the brain of affected individuals the typical foamy cells with the oligodendroglial phenotype described in central hypomyelination syndrome/vanishing white matter, a syndrome related to mutations in the genes encoding the five subunits of the eucaryotic translation initiation factor eIF2B. In three patients of two Cree families, we found a homozygous missense mutation resulting in a histidine substitution at arginine 195 of epsilon-eIF2B.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325082     DOI: 10.1002/ana.10339

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  34 in total

1.  Late onset vanishing white matter disease.

Authors:  Axel Riecker; Thomas Nägele; Marco Henneke; Ludger Schöls
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

2.  Case 1: The importance of a complete history.

Authors:  Kent Saylor
Journal:  Paediatr Child Health       Date:  2005-11       Impact factor: 2.253

3.  Old meets new: identifying founder mutations in genetic disease.

Authors:  Jane A Evans
Journal:  CMAJ       Date:  2015-01-19       Impact factor: 8.262

4.  Clinical and neuroimaging findings of Cree leukodystrophy: a retrospective case series.

Authors:  S Harder; A Gourgaris; E Frangou; K Hopp; R Huntsman; N Lowry; S Seshia; E Lemire; C Robinson; J Tynan
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-29       Impact factor: 3.825

Review 5.  Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease.

Authors:  Stefanie Gerstberger; Markus Hafner; Manuel Ascano; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

6.  Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients.

Authors:  Liraz Kantor; Heather P Harding; David Ron; Raphael Schiffmann; Christine R Kaneski; Scot R Kimball; Orna Elroy-Stein
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

7.  Astrocytes are central in the pathomechanisms of vanishing white matter.

Authors:  Stephanie Dooves; Marianna Bugiani; Nienke L Postma; Emiel Polder; Niels Land; Stephen T Horan; Anne-Lieke F van Deijk; Aleid van de Kreeke; Gerbren Jacobs; Caroline Vuong; Jan Klooster; Maarten Kamermans; Joke Wortel; Maarten Loos; Lisanne E Wisse; Gert C Scheper; Truus E M Abbink; Vivi M Heine; Marjo S van der Knaap
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

8.  eIF2B-related disorders: antenatal onset and involvement of multiple organs.

Authors:  Marjo S van der Knaap; Carola G M van Berkel; Jochen Herms; Rudy van Coster; Martina Baethmann; Sakkubai Naidu; Eugen Boltshauser; Michèl A A P Willemsen; Barbara Plecko; Georg F Hoffmann; Christopher G Proud; Gert C Scheper; Jan C Pronk
Journal:  Am J Hum Genet       Date:  2003-10-17       Impact factor: 11.025

9.  An autopsy case of infantile-onset vanishing white matter disease related to an EIF2B2 mutation (V85E) in a hemizygous region.

Authors:  Yukiko Hata; Koshi Kinoshita; Kazushi Miya; Keiichi Hirono; Fukiko Ichida; Koji Yoshida; Naoki Nishida
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

10.  Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.

Authors:  Laetitia Horzinski; Aurélia Huyghe; Marie-Céleste Cardoso; Céline Gonthier; Lemlih Ouchchane; Raphael Schiffmann; Pierre Blanc; Odile Boespflug-Tanguy; Anne Fogli
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.